SLC2A1 and cancer: Notably, we also demonstrated that the disruption of GLUT1 decreases glycolytic activity and thereby depresses the enhanced stemness induced by CD44v10 upregulation, providing a novel mechanism by which CD44 variants confer stem-like properties of cancer cells.